N-(3,5-difluorophenyl)-2-(4-(4-fluorophenyl)-1-methyl-1H-pyrazolo[3,4-b]pyridin-6-yl)hydrazine-1-carboxamide

ID: ALA5186737

Chembl Id: CHEMBL5186737

PubChem CID: 168282685

Max Phase: Preclinical

Molecular Formula: C20H15F3N6O

Molecular Weight: 412.38

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1ncc2c(-c3ccc(F)cc3)cc(NNC(=O)Nc3cc(F)cc(F)c3)nc21

Standard InChI:  InChI=1S/C20H15F3N6O/c1-29-19-17(10-24-29)16(11-2-4-12(21)5-3-11)9-18(26-19)27-28-20(30)25-15-7-13(22)6-14(23)8-15/h2-10H,1H3,(H,26,27)(H2,25,28,30)

Standard InChI Key:  AHICCJKXQBAMBU-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5186737

    ---

Associated Targets(Human)

S1PR2 Tchem Sphingosine 1-phosphate receptor Edg-5 (1593 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SW620/5-FU (115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 412.38Molecular Weight (Monoisotopic): 412.1259AlogP: 4.20#Rotatable Bonds: 4
Polar Surface Area: 83.87Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.94CX Basic pKa: 1.38CX LogP: 4.25CX LogD: 4.25
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.44Np Likeness Score: -1.88

References

1. Luo D, Guo Z, Zhao X, Wu L, Liu X, Zhang Y, Zhang Y, Deng Z, Qu X, Cui S, Wan S..  (2022)  Novel 5-fluorouracil sensitizers for colorectal cancer therapy: Design and synthesis of S1P receptor 2 (S1PR2) antagonists.,  227  [PMID:34688013] [10.1016/j.ejmech.2021.113923]

Source